ORMP

4.04

3.35% -0.14

Dopo l'orario di chiusura: 4.04

Oramed Pharmaceuticals Inc (ORMP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$4.18

Aprire:

$4.18

Volume 24 ore:

226.89K

Relative Volume:

0.80

Capitalizzazione di mercato:

$165.34M

Reddito:

$2.00M

Utile/perdita netta:

$109.16M

Rapporto P/E:

1.5638

EPS:

2.5835

Flusso di cassa netto:

$-9.11M

1 W Prestazione:

-12.17%

1M Prestazione:

+9.19%

6M Prestazione:

+17.78%

1 anno Prestazione:

+90.57%

Intervallo 1D:

$4.035

$4.22

Intervallo di 1 settimana:

$4.035

$4.73

Portata 52W:

$1.975

$5.19

Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile

Nome

Oramed Pharmaceuticals Inc

Settore

Healthcare (1096)

Industria

Biotechnology (616)

Telefono

646-844-1164

Indirizzo

1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY

Dipendente

Cinguettio

@OramedPharma

Prossima data di guadagno

2026-08-13

Ultimi documenti SEC

ORMP's Discussions on Twitter

Compare ORMP vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ORMP Oramed Pharmaceuticals Inc	4.04	165.34M	2.00M	109.16M	-9.11M	2.5835
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-01-12	Downgrade	Canaccord Genuity	Buy → Hold
2022-02-18	Iniziato	Cantor Fitzgerald	Overweight
2021-04-20	Iniziato	Canaccord Genuity	Buy
2021-02-09	Iniziato	National Securities	Buy
2020-12-03	Iniziato	Alliance Global Partners	Buy
2020-03-11	Iniziato	Aegis Capital	Buy
2019-09-11	Iniziato	Ladenburg Thalmann	Buy
2017-12-11	Ripresa	B. Riley FBR, Inc.	Buy
2016-05-26	Reiterato	FBR Capital	Outperform
2015-12-01	Reiterato	H.C. Wainwright	Buy
2015-11-19	Iniziato	FBR Capital	Outperform
2015-04-13	Ripresa	MLV & Co	Buy
2014-01-30	Reiterato	Aegis Capital	Buy
2014-01-08	Reiterato	Aegis Capital	Buy
2014-01-08	Iniziato	MLV & Co	Buy
2013-12-03	Iniziato	Aegis Capital	Buy

Mostra tutto

Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie

Jul 09, 2026

Price to sales forward of Oramed Pharmaceuticals Inc. – NASDAQ:ORMP - TradingView

Jul 09, 2026

Jul 08, 2026

Enterprise value to EBIT forward of Oramed Pharmaceuticals Inc. – NASDAQ:ORMP - TradingView

Jul 08, 2026

Oramed Pharmaceuticals highlights oral drug platform as investors assess long-term prospects - ad-hoc-news.de

Jul 08, 2026

Jul 07, 2026

Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet - AOL.com

Jul 07, 2026

Oramed Pharmaceuticals outlines its oral drug strategy as Nasdaq-listed biotech pursues long-term gr - ad-hoc-news.de

Jul 07, 2026

Jul 05, 2026

Price to earnings forward of Oramed Pharmaceuticals Inc. – NASDAQ:ORMP - TradingView

Jul 05, 2026

Jul 03, 2026

Oramed Pharmaceuticals stock holds its ground. Investors await the next company update. - ad-hoc-news.de

Jul 03, 2026

Jul 02, 2026

ORAMED (NASDAQ: ORMP) CFO executes pre-planned sale of 73,360 shares - Stock Titan

Jul 02, 2026

Oramed Pharmaceuticals Incorporated Financial Disclosures & SEC Filings - TradingView

Jul 02, 2026

Jul 01, 2026

Form 144 ORAMED PHARMACEUTICALS INC. For: 1 July By Investing.com - Investing.com South Africa

Jul 01, 2026

137,000 shares flagged for sale by Oramed (NASDAQ: ORMP) in Form 144 - Stock Titan

Jul 01, 2026

Oramed (NASDAQ: ORMP) Form 144 notes 93,360 RSU shares on 06/18/2026 - Stock Titan

Jul 01, 2026

Oramed Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Jul 01, 2026

Jun 30, 2026

Oramed Pharm Updates Bylaws, Streamlining Shareholder Actions - TipRanks

Jun 30, 2026

Oramed (NASDAQ: ORMP) revises bylaws and restructures Scilex note obligations - Stock Titan

Jun 30, 2026

Jun 29, 2026

Oramed Pharmaceuticals Inc.(NasdaqCM: ORMP) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026

Oramed Pharmaceuticals Inc.(NasdaqCM: ORMP) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

BML Investment Holds 2.5% of Oramed (ORMP) in Amended 13G/A - Stock Titan

Jun 29, 2026

Oramed Pharmaceuticals Inc.(NasdaqCM: ORMP) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell 2000 Value-Defensive Index - marketscreener.com

Jun 28, 2026

Oramed Pharmaceuticals Inc.(NasdaqCM: ORMP) added to Russell 2500 Value Benchmark - marketscreener.com

Jun 28, 2026

Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Oramed Pharmaceuticals Incorporated Actuals & Estimates (MUN:OJU1) - TradingView

Jun 26, 2026

Oramed Pharmaceuticals Incorporated Actuals & Estimates (DUS:OJU1) - TradingView

Jun 26, 2026

These healthcare stocks are combining strong gains with reasonable prices - MSN

Jun 26, 2026

Jun 25, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Jun 25, 2026

Oramed Releases Letter to Shareholders, Highlighting Russell 200 - GuruFocus

Jun 25, 2026

Oramed Pharmaceuticals Incorporated Actuals & Estimates (NASDAQ:ORMP) - TradingView

Jun 25, 2026

Oramed's Pivot Pays Off: From Pharma Hopeful to Investment Powerhouse - BriefGlance

Jun 25, 2026

Jun 23, 2026